{
    "symbol": "HRTX",
    "quarter": 4,
    "year": 2022,
    "date": "2023-03-23 21:08:06",
    "content": " Finally, we\u00e2\u0080\u0099ve also provided ZYNRELEF\u00e2\u0080\u0099s branded market share for the top five IDN accounts out of the 15 IDNs evaluating therapeutic interchange from EXPAREL to ZYNRELEF and this table demonstrates our branded market share can grow very quickly to an approach to a high approaching 50% for the fourth quarter based on our current indicated procedures, 50% is approaching the upper limit of what we expect to receive until an additional label expansion, which is expected in October of this year."
}